Lauren Crowe

About Lauren Crowe

Sometimes it’s hard to know what has been most exciting so far…leading a $120M Series D financing, gaining alignment across stakeholders to successfully complete a $90M restructuring, or partnering daily with commercial and product teams to drive customer growth and margin expansion.I’ve had the opportunity to navigate them multiple times across different organizations, building finance functions that operate with rigor, accuracy, and collaboration while serving as trusted strategic partners to the business.My approach is grounded in playing to strengths, both my own and those of the teams I build and lead. I bring a positive, driven mindset, communicate openly, and move initiatives forward with clarity and decisiveness. These strengths have enabled several key accomplishments:• Led the $1B merger integration between Standard BioTools and SomaLogic, delivering $90M in annualized costsynergies within the first year • Built and scaled the global finance organization at SomaLogic and Standard BioTools, supporting executive leadership through a major merger and organizational transition • Created and scaled the finance and accounting function at Classy, including leading a $120M Series D financing, refinancing a $30M loan, and supporting the company’s acquisition by GoFundMe • Drove margin expansion and growth initiatives across global divisions at Thermo Fisher ScientificThe most effective finance organizations are not just stewards of the numbers, they serve as catalysts for clarity, accountability, and better strategic decision-making.My experience spans public and private companies across life sciences, SaaS, and technology, with a focus on organizations navigating growth, operational complexity, and strategic change.I am a data-driven strategic leader who enables business leaders to make confident decisions that drive meaningful outcomes for customers and create long-term shareholder value.I’m always looking to expand my network and welcome the opportunity to connect.Core Competencies: Financial Modeling & Reporting | Budgeting & Forecasting | Cost Control | GAAP | Auditing | Risk Assessment | Margin Expansion | Capital Allocation | Pricing Strategy | M&A | Due Diligence | Process Improvement | Performance Optimization | Systems Automation | Go-To-Market Strategy | Investor Presentations & Communications | Talent Development | Executive CommunicationStrengths Finder: Achiever, Harmony, Empathy, Positivity, Arranger

Experience

1. Global Vice President of Finance

   Standard BioTools

   Jan 2024 — Present · Remote/Boston, MA, US

   Bootstrapped the FP & A and finance business partnering function. Key partner to the COO, enabling the commercial teams to provide accurate forecasts and future planning for the organization. Manage and develop high-performing global teams through periods of growth, integration, and workforce reduction, maintaining strong engagement, clarity of priorities, and open communication. Proven track record as a value-driven leader, fostering transparent, accountable, and safe team cultures while aligning day-to-day work with enterprise strategy.Drove investor relations in coordination with external advisors, encompassing earnings materials, investor presentations, and press releases; consistently met top-line AOP and external guidance for six consecutive quarters.Led major EBITDA turnaround by reducing cost as a percentage of revenue amid a slow-growth competitive environment.Frequently selected by the executive leadership team to contribute to enterprise-wide leadership initiatives, including programs focused on increasing employee engagement and aligning day-to-day work with corporate strategy and purpose.

Education

• University of Missouri-Saint Louis

  Bachelor of Science (B.S.), Economics

• University of Missouri-Saint Louis

  Master of Arts (M.A.), Economics

Skills

• Financial Reporting
• User Documentation
• Financial Analysis
• Financial Modeling
• Budgeting
• Accounts Receivable
• Cash Flow
• Bank Reconciliation
• Accounts Payable